Published in J Immunol on July 01, 2008
Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci U S A (2011) 1.51
Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol (2010) 1.46
Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog (2014) 1.27
Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity. J Immunol (2012) 1.21
Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection. J Leukoc Biol (2012) 1.14
Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond) (2010) 1.06
PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nucl Recept Signal (2010) 0.98
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. Am J Pathol (2009) 0.97
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. PLoS One (2011) 0.96
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators Inflamm (2010) 0.93
Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med (2014) 0.90
The co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions. Cell Microbiol (2015) 0.85
Young microglia restore amyloid plaque clearance of aged microglia. EMBO J (2016) 0.80
Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes. BMC Immunol (2013) 0.79
15-Deoxy-Δ¹²,¹⁴ prostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. PLoS One (2011) 0.77
Quantitative microscopy in murine models of lung inflammation. Anal Quant Cytol Histol (2011) 0.75
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
The many faces of macrophage activation. J Leukoc Biol (2003) 8.95
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature (2005) 6.83
The mechanisms of action of PPARs. Annu Rev Med (2002) 6.71
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science (1994) 4.81
CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol (2004) 4.02
Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol (2002) 3.82
Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol (2005) 3.67
Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem (1998) 3.27
GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity (2001) 3.13
Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol (2002) 3.02
Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med (1984) 3.02
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93
Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy (1995) 2.14
Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol (2000) 2.12
ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol (2005) 2.03
Macrophage differentiation to foam cells. Curr Pharm Des (2005) 1.77
Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord (2003) 1.77
The role of PPARs in inflammation and immunity. J Leukoc Biol (2002) 1.74
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J Biol Chem (2000) 1.68
Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol Metab (2006) 1.57
Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol (2006) 1.55
Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.50
Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors. J Biol Chem (2007) 1.46
The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol (2005) 1.39
Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol (2003) 1.37
Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest (2004) 1.34
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res (2007) 1.34
Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol (2001) 1.33
The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol (1999) 1.28
Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor. Blood (1987) 1.26
Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J Immunol (2003) 1.18
PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation. J Biol Chem (2004) 1.17
CSF-1 as a regulator of macrophage activation and immune responses. Arch Immunol Ther Exp (Warsz) (2003) 1.14
Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol (2002) 1.14
Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol (2003) 1.13
Identifying cooperative transcriptional regulations using protein-protein interactions. Nucleic Acids Res (2005) 1.09
Combining chromatin immunoprecipitation and DNA footprinting: a novel method to analyze protein-DNA interactions in vivo. Nucleic Acids Res (2002) 1.08
Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol (2000) 1.02
Monocyte survival factors induce Akt activation and suppress caspase-3. Am J Respir Cell Mol Biol (2002) 1.00
Bisphenol a diglycidyl ether (BADGE) suppresses tumor necrosis factor-alpha production as a PPARgamma agonist in the murine macrophage-like cell line, RAW 264.7. Cell Biol Int (2002) 0.92
The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter. Biochem Biophys Res Commun (2001) 0.90
Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategies. Treat Respir Med (2004) 0.90
Macrophage colony-stimulating-factor (M-CSF or CSF-1) and its receptor: structure-function relationships. Eur Cytokine Netw (1997) 0.86
Route of monocyte differentiation determines their cytokine production profile: CD40 ligation induces interleukin 10 expression. Cytokine (2000) 0.86
Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis. Biochim Biophys Acta (1996) 0.84
Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor. J Leukoc Biol (2005) 0.84
Regulation of CD154-induced interleukin-12 production in synovial fluid macrophages. Arthritis Res (2002) 0.83
Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation. Blood (2003) 0.82
Prostaglandin and PPAR control of immune cell function. Immunology (2002) 0.81
Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity (2003) 0.80
Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1). Biochem J (2001) 0.78
Transcriptional regulation of the expression of macrophage colony stimulating factor. Mol Cell Endocrinol (2000) 0.77
Analysis of the mouse CSF-1 gene promoter in a transgenic mouse model. J Histochem Cytochem (2003) 0.77
Effect of macrophage colony stimulating factor overexpression on oxidative injury/resistance of RAW264.7 cells. Clin Exp Med (2003) 0.76
Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol (2006) 4.87
The isolation and characterization of murine macrophages. Curr Protoc Immunol (2008) 4.86
Interleukin-10: new perspectives on an old cytokine. Immunol Rev (2008) 3.94
Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol (2007) 2.51
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med (2005) 2.50
NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem (2006) 2.29
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis (2010) 2.24
Therapeutic Whole-Lung Lavage for Pulmonary Alveolar Proteinosis: A Procedural Update. J Bronchology Interv Pulmonol (2015) 2.04
ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol (2005) 2.03
Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol (2002) 2.02
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood (2003) 1.97
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest (2005) 1.94
A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol (2002) 1.91
Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol (2012) 1.86
Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res (2009) 1.84
Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol (2006) 1.83
Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med (2006) 1.82
The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol (2002) 1.79
Draft genome of the kiwifruit Actinidia chinensis. Nat Commun (2013) 1.72
Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit Care Med (2012) 1.61
Contrasting effects of different maternal diets on sexually dimorphic gene expression in the murine placenta. Proc Natl Acad Sci U S A (2010) 1.58
Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem (2005) 1.57
Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol (2006) 1.55
Case series: Tension pneumothorax complicating narrow-bore enteral feeding tube placement. J Intensive Care Med (2010) 1.50
An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest (2006) 1.48
PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol (2003) 1.44
Regulatory macrophages: setting the threshold for therapy. Eur J Immunol (2011) 1.40
Syndrome of iron pill aspiration. Chest (2002) 1.39
Steroids combined with levothyroxine to treat children with idiopathic nephrotic syndrome: a retrospective single-center study. Pediatr Nephrol (2014) 1.38
Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol (2003) 1.37
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell (2012) 1.37
High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.34
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res (2007) 1.34
Magnetic study on a two-dimensional coordination polymer with mixed bridging ligands. J Phys Chem A (2006) 1.32
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH. J Mol Diagn (2013) 1.30
Activation of murine macrophages. Curr Protoc Immunol (2008) 1.30
Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med (2009) 1.30
Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood (2003) 1.29
Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol (2002) 1.29
Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J Exp Med (2011) 1.28
Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci (2004) 1.28
TAC1, a major quantitative trait locus controlling tiller angle in rice. Plant J (2007) 1.27
Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res (2004) 1.27
Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. J Immunol (2009) 1.23
Epigenetic regulation, somatic homologous recombination, and abscisic acid signaling are influenced by DNA polymerase epsilon mutation in Arabidopsis. Plant Cell (2009) 1.23
Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol (2013) 1.23
Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics (2005) 1.22
Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol (2007) 1.22
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst (2005) 1.21
TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Res (2003) 1.20
Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology (2003) 1.20
Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun (2009) 1.19
Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med (2011) 1.17
Spinal cord neurosarcoidosis. Am J Med Sci (2014) 1.17
Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke (2007) 1.16
Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma. Clin Cancer Res (2014) 1.15
Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol (2002) 1.14
Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol (2003) 1.13
Full-thickness endoscopic resection of nonintracavitary gastric stromal tumors: a novel approach. Surg Endosc (2010) 1.11
The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett (2010) 1.11
Bacillus thuringiensis bel protein enhances the toxicity of Cry1Ac protein to Helicoverpa armigera larvae by degrading insect intestinal mucin. Appl Environ Microbiol (2009) 1.10
Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology (2008) 1.09
Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur Respir J (2012) 1.08
β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. Cancer Res (2013) 1.08
Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes. Am J Respir Cell Mol Biol (2011) 1.08
Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states. J Neurosci (2012) 1.07
Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res (2012) 1.07
Idiopathic pulmonary fibrosis or not: antibiotic prophylaxis for all patients on immunosuppressants. Thorax (2013) 1.07
The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells. Biochem Biophys Res Commun (2010) 1.07
Biobanking of fresh-frozen human colon tissues: impact of tissue ex-vivo ischemia times and storage periods on RNA quality. Ann Surg Oncol (2012) 1.07
T cell biasing by activated dendritic cells. J Immunol (2004) 1.07
TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood (2013) 1.06
Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol (2004) 1.06
Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21. Proc Natl Acad Sci U S A (2004) 1.05
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One (2013) 1.05
The expression of exogenous genes in macrophages: obstacles and opportunities. Methods Mol Biol (2009) 1.05
Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol (2012) 1.04
Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res (2010) 1.04
Tunable full-color emitting BaMg2Al6Si9O30:Eu2+, Tb3+, Mn2+ phosphors based on energy transfer. Inorg Chem (2011) 1.04
TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology (2006) 1.03
In vitro antioxidant and antiproliferative activities of 5-hydroxymethylfurfural. J Agric Food Chem (2013) 1.03
Modulating macrophage function with IgG immune complexes. J Endotoxin Res (2002) 1.02
Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells (2012) 1.01
Strain and sex differences in anxiety-like and social behaviors in C57BL/6J and BALB/cJ mice. Exp Anim (2011) 1.01